University of California, Los Angeles Medical Center — Los Angeles, California

Public research footprint of University of California, Los Angeles Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIA Fallopian Tube Cancer AJCC v6 and v7 · Stage IIA Ovarian Cancer AJCC V6 and v7 · Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung… · Stage IIB Fallopian Tube Cancer AJCC v6 and v7

Recently updated registry entries

NCT07023627 — A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT05788536 — A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California, Los Angeles Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.